(Q45091849)

9 December 2017

0 references

Chemotherapy and immunomodulation: from immunogenic chemotherapies to novel therapeutic strategies (English)

1 reference

9 December 2017

1 reference

2

1 reference

9 December 2017

author name string

Francois Ghiringhelli

series ordinal

1

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

9 December 2017

1 reference

9 December 2017

volume

9

1 reference

9 December 2017

issue

4

1 reference

9 December 2017

page(s)

469-472

1 reference

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Immunogenicity of anthracyclines: moving towards more personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Immunological aspects of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.207

21 January 2018

Identifiers

DOI

10.2217/FON.12.207

1 reference

9 December 2017

1 reference